Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Rasmussen

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Frontiers in Medicine|July 9, 2025
<i>Pseudomonas aeruginosa</i> elastase down-regulates host inflammatory responses by degrading cytokines and chemokines: a non-healing wound perspectiveMariena J A van der Plas, Manoj Puthia, Seow Theng Ong, et al.
The Journal of Infectious Diseases|February 21, 2004
Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive diseasePer Akesson, Magnus Rasmussen, Ellen Mascini, et al.
Infection Ecology & Epidemiology|October 16, 2020
Serology assessment of antibody response to SARS-CoV-2 in patients with COVID-19 by rapid IgM/IgG antibody testYang De Marinis, Torgny Sunnerhagen, Pradeep Bompada, et al.
Plos One|May 12, 2011
Microspectroscopic evidence of cretaceous bone proteinsJohan Lindgren, Per Uvdal, Anders Engdahl, et al.
Nature Communications|February 24, 2025
Dissecting the properties of circulating IgG against streptococcal pathogens through a combined systems antigenomics-serology workflowAlejandro Gomez Toledo, Sounak Chowdhury, Elisabeth Hjortswang, et al.
BMC Research Notes|December 5, 2021
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern SwedenKarin Holm, Maria N Lundgren, Jens Kjeldsen-Kragh, et al.
Infectious Diseases (London, England)|December 8, 2021
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 casesOskar Ljungquist, Maria Lundgren, Elena Iliachenko, et al.
American Heart Journal|July 17, 2020
Accelerated treatment of endocarditis-The POET II trial: Rationale and design of a randomized controlled trialLauge Østergaard, Mia Marie Pries-Heje, Rasmus Bo Hasselbalch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2024
External Validation of the 2023 Duke-International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective EndocarditisThomas W van der Vaart, Patrick M M Bossuyt, David T Durack, et al.
Frontiers in Immunology|January 31, 2022
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2Wael Bahnan, Sebastian Wrighton, Martin Sundwall, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Frontiers in Medicine|July 9, 2025
<i>Pseudomonas aeruginosa</i> elastase down-regulates host inflammatory responses by degrading cytokines and chemokines: a non-healing wound perspectiveMariena J A van der Plas, Manoj Puthia, Seow Theng Ong, et al.
The Journal of Infectious Diseases|February 21, 2004
Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive diseasePer Akesson, Magnus Rasmussen, Ellen Mascini, et al.
Infection Ecology & Epidemiology|October 16, 2020
Serology assessment of antibody response to SARS-CoV-2 in patients with COVID-19 by rapid IgM/IgG antibody testYang De Marinis, Torgny Sunnerhagen, Pradeep Bompada, et al.
Plos One|May 12, 2011
Microspectroscopic evidence of cretaceous bone proteinsJohan Lindgren, Per Uvdal, Anders Engdahl, et al.
Nature Communications|February 24, 2025
Dissecting the properties of circulating IgG against streptococcal pathogens through a combined systems antigenomics-serology workflowAlejandro Gomez Toledo, Sounak Chowdhury, Elisabeth Hjortswang, et al.
BMC Research Notes|December 5, 2021
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern SwedenKarin Holm, Maria N Lundgren, Jens Kjeldsen-Kragh, et al.
Infectious Diseases (London, England)|December 8, 2021
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 casesOskar Ljungquist, Maria Lundgren, Elena Iliachenko, et al.
American Heart Journal|July 17, 2020
Accelerated treatment of endocarditis-The POET II trial: Rationale and design of a randomized controlled trialLauge Østergaard, Mia Marie Pries-Heje, Rasmus Bo Hasselbalch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2024
External Validation of the 2023 Duke-International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective EndocarditisThomas W van der Vaart, Patrick M M Bossuyt, David T Durack, et al.
Frontiers in Immunology|January 31, 2022
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2Wael Bahnan, Sebastian Wrighton, Martin Sundwall, et al.
Pageof 17